A 32-year-old man with pulmonary TB is found to be resistant to isoniazid and rifampicin on drug susceptibility testing. Further testing reveals susceptibility to fluoroquinolones and injectable agents (amikacin, capreomycin). Which feature best distinguishes MDR-TB from XDR-TB in this patient's profile?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.